Processing

Please wait...

Settings

Settings

Goto Application

1. WO1996005729 - VICINAL-SUBSTITUTED CARBOCYCLIC COMPOUNDS AS THERAPEUTIC AGENTS

Publication Number WO/1996/005729
Publication Date 29.02.1996
International Application No. PCT/US1995/008523
International Filing Date 13.07.1995
Chapter 2 Demand Filed 15.03.1996
IPC
C07C 235/84 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
235Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
70having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
84with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
CPC
C07C 235/84
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
235Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
70having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
84with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
C07C 2601/08
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
2601Systems containing only non-condensed rings
06with a five-membered ring
08the ring being saturated
Applicants
  • ELI LILLY AND COMPANY [US]/[US]
Inventors
  • JAGDMANN, G., Erik, Jr.
Agents
  • LAMMERT, Steven, R.
Priority Data
08/292,75318.08.1994US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) VICINAL-SUBSTITUTED CARBOCYCLIC COMPOUNDS AS THERAPEUTIC AGENTS
(FR) COMPOSES CARBOCYCLIQUES A SUBSTITUTION VICINALE UTILISES COMME AGENTS THERAPEUTIQUES
Abstract
(EN)
Compounds having formula (I) are useful as inhibitors of protein kinase C. Also disclosed are pharmaceutical compositions including such compounds and methods for using such compounds to inhibit protein kinase C in animals, including man.
(FR)
Composés de formule (I) pouvant être utilisés comme inhibiteurs de la protéine kinase C. On décrit également des préparations pharmaceutiques comprenant ces composés, ainsi que des procédés d'utilisation de ces composés pour inhiber la protéine kinase C chez les animaux et les humains.
Also published as
Latest bibliographic data on file with the International Bureau